Please login to the form below

Not currently logged in
Email:
Password:

Storm Therapeutics

This page shows the latest Storm Therapeutics news and features for those working in and with pharma, biotech and healthcare.

STORM Therapeutics receives Innovate UK grant

STORM Therapeutics receives Innovate UK grant

STORM Therapeutics, a University of Cambridge spin-out specialising on small molecule therapies targeting RNA epigenetic mechanisms, has been awarded a Biomedical Catalyst grant by Innovate UK. ... Tim Edwards, Chairman of STORM Therapeutics, said: “We

Latest news

  • RNA-focused biotech Storm Therapeutics raises extra £14m RNA-focused biotech Storm Therapeutics raises extra £14m

    New head of translational oncology also hired. Storm Therapeutics, the UK-based biotech specialising in modulating RNA modifying enzymes has announced that it has raised an extra £14m ($17.8m) from ... Keith Blundy. Dr Keith Blundy, chief executive of

More from news
Approximately 2 fully matching, plus 0 partially matching documents found.

Latest appointments

  • Professor Thomas Cech joins Storm Therapeutics Professor Thomas Cech joins Storm Therapeutics

    He takes up a scientific advisor role at the group. Storm Therapeutics, a company focused on the discovery of small molecule therapies has appointed Professor Thomas Cech as its scientific advisor. ... Commenting on the new appointments, Keith Blundy,

  • Storm Therapeutics bolsters its team Storm Therapeutics bolsters its team

    UK-based drug discovery group Storm Therapeutics has strengthened its scientific advisory board with the addition of Professor Mark Dawson. ... Keith Blundy, chief executive officer of Storm Therapeutics, said: “Mark’s expertise in epigenetics

  • Storm Therapeutics strengthens its board Storm Therapeutics strengthens its board

    Professor Paul Workman joins as an independent director. Drug discovery group Storm Therapeutics has appointed Professor Paul Workman to join its board. ... UK. Keith Blundy, CEO, Storm Therapeutics, said: “I am pleased to welcome Paul as indepdent

More from appointments
Approximately 3 fully matching, plus 0 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Medscape Education Global

Medscape delivers dynamic, innovative education to optimize learner engagement and patient outcomes worldwide....

Latest intelligence

Our Top 5 Pharma Picks From Cannes Lions
Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
The Evolving Role of the Sales Rep
The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
Measure your omnichannel maturity with our new tool
Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....